H.C. Wainwright analyst Matt Keller assumes coverage on Acurx Pharmaceuticals inc. (NASDAQ: ACXP) with a Buy rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE